India Completes COVID-19 Vaccination Of 1.63 Crore Beneficiaries

In India, the cumulative number of Covid-19 vaccine doses administered crossed 1.63 crore on Wednesday.

The nation-wide vaccination drive was rolled out on January 16 with healthcare workers being inoculated against the virus. Vaccination of the frontline workers began on February 2.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘COVID-19 in India: Out of which, 5,79,366 beneficiaries were vaccinated for 1st dose and 1,13,523 health care workers and frontline workers received 2nd dose of vaccine as per the provisional report. ’

Tweet it Now

The second leg of the inoculation drive commenced on March 1 for those who are over 60 years of age and for people aged 45 and above with specified co-morbid conditions.

A total of 1,63,14,485 vaccine doses have been given, as per the provisional report till 7 pm on Wednesday.

These include 67,75,619 healthcare workers who have taken the 1st dose and 28,24,311 health care workers who have taken the 2nd dose, 57,62,131 frontline workers (1st dose), 3,277 frontline workers (2nd dose).

COVID-19 Vaccine Update: Private Prices Capped at ₹250 a Shot
People eligible for the next phase of COVID-19 vaccination beginning March 1 can walk up to a vaccination centre to be registered for a dose, said Indian Union government while outlining new guidelines and features of the Co-WIN platform.

About 8,44,884 beneficiaries more than 60 years old and 1,04,263 beneficiaries aged 45 and above with specific co-morbidities have also taken it till now.

Total 6,92,889 vaccine doses were given till 7 pm today, the forty-seventh day of nationwide vaccination.

Home Minister Amit Shah Gets COVID-19 Vaccine
Home Minister Amit Shah gets COVID-19 shot in phase 2 of the inoculation drive. Shah, 56, took the vaccination on Monday under supervision of staff from Medanta The Medicity.

Source-IANS

US Panel Endorses Johnson & Johnson COVID-19 Vaccine for Emergency Approval
A high powered US vaccine advisory panel endorsed mass use of a single dose Johnson & Johnson Covid-19 vaccine.